Studies on the tryptophan and drug-binding properties of human serum albumin fragments by affinity chromatography and circular dichroism measurements.
D000409:Alanine; D000596:Amino Acids / Q000032:analysis; D055598:Chemical Phenomena; D002621:Chemistry; D002707:Chlordiazepoxide / Q000378:metabolism*; D002846:Chromatography, Affinity; D002942:Circular Dichroism; D003488:Cyanogen Bromide; D003956:Dialysis; D004589:Electrophoresis, Disc; D005029:Ethylenediamines; D006801:Humans; D008433:Mathematics; D010446:Peptide Fragments / Q000302:isolation & purification; D010455:Peptides / Q000032:analysis; D010640:Phenothiazines / Q000378:metabolism*; D010653:Phenylbutazone / Q000378:metabolism*; D011134:Polysaccharides; D011485:Protein Binding; D011487:Protein Conformation; D012709:Serum Albumin / Q000032:analysis / Q000378:metabolism*; D014364:Tryptophan / Q000378:metabolism*; D014466:Ultraviolet Rays
D000596:Amino Acids; D005029:Ethylenediamines; D010446:Peptide Fragments; D010455:Peptides; D010640:Phenothiazines; D011134:Polysaccharides; D012709:Serum Albumin; D002707:Chlordiazepoxide; D014364:Tryptophan; D010653:Phenylbutazone; D000409:Alanine; D003488:Cyanogen Bromide